InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Zago Wagner M., Directeur Scientifique. Officer active across 1 company, notably Prothena CORP Public Ltd Co. Aggregated, 7 filings have been published. History available since 22 June 2021. The latest transaction was disclosed on 28 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Zago Wagner M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
51,000 股Ordinary Shares, par value $0.01 per shareSEC:0000905148-26-003417:0
51,000 股@ US$8.560.099% mcap33.5% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-26-003417:1
85,000 股0Ordinary Shares, par value $0.01 per shareSEC:0000905148-25-002662:0
4,000 股@ US$12.154.4% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-037713:0
4,000 股@ US$12.154.4% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-033192:0
15,000 股@ US$29.8141.2% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-028870:0
15,000 股@ US$20.1733.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-21-012571:0
7 条申报中的 7 条
About Zago Wagner M.
Zago Wagner M. is the Chief Scientific Officer at Prothena Corp Public Ltd Co. In this role, he oversees research and the development of new treatments. His scientific expertise is crucial for innovation and advancing the company's projects.
